Latest BioLineRx News & Updates

See the latest news and media coverage for BioLineRx. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
BioLineRx

Biopharmaceutical company focused on oncology and rare diseases

biolinerx.com
Headquarters
Modi'​in, Israel
Founded year
2003
Company type
Public company
Number of employees
40–50

Last updated

Latest news about BioLineRx

In short: BioLineRx progressed its oncology pipeline by initiating a Phase 1/2a trial for GLIX1 and reported a Q1 2026 earnings beat with a stable cash runway.

Company announcements

BioLineRx

BioLineRx reports 2025 financial results and corporate update

The company expects to initiate a Phase 1/2a GLIX1 trial in glioblastoma by March end, maintains cash runway into H1 2027, and reported a net loss of $2.0 million.

Unlock all announcements with a

Media coverage

Yahoo Finance

BioLineRx and Hemispherian AS Highlight New Data on GLIX1 at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a clinical-stage oncology company...

Unlock all articles with a

Never miss news about BioLineRx

Track BioLineRx and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

BioLineRx competitors & trending companies

Browse news for competitors to BioLineRx and other trending companies.